Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

156
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
156
Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

268
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
268
Irritable Bowel Syndrome III: Medical and Nursing Management01:30

Irritable Bowel Syndrome III: Medical and Nursing Management

195
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
195
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

159
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
159
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

440
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
440
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

157
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
157

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

What is causing this patient's recurrent small bowel obstructions?

JAAPA : official journal of the American Academy of Physician Assistants·2026
Same journal

The evolution of the PA profession in Switzerland.

JAAPA : official journal of the American Academy of Physician Assistants·2026
Same journal

Use of dermoscopy and its association with skin lesion evaluation confidence among PAs in the United States.

JAAPA : official journal of the American Academy of Physician Assistants·2026
Same journal

Diabetic myonecrosis.

JAAPA : official journal of the American Academy of Physician Assistants·2026
Same journal

Acute coronary syndrome during active infusion of andexanet alfa.

JAAPA : official journal of the American Academy of Physician Assistants·2026
Same journal

Empowering PAs in health care: Unlocking the potential of implementation science.

JAAPA : official journal of the American Academy of Physician Assistants·2026
Same journal

The surgeon's tale.

JAAPA : official journal of the American Academy of Physician Assistants·2026
See all related articles

Related Experiment Video

Updated: Jun 24, 2025

Perturbations of Circulating miRNAs in Irritable Bowel Syndrome Detected Using a Multiplexed High-throughput Gene Expression Platform
10:37

Perturbations of Circulating miRNAs in Irritable Bowel Syndrome Detected Using a Multiplexed High-throughput Gene Expression Platform

Published on: November 30, 2016

8.3K

Irritable bowel syndrome: Clinical practice update.

Kimberly A Carter1

  • 1Kimberly A. Carter is director of clinical education and an associate professor in the PA program at Midwestern University in Glendale, Ariz. The author has disclosed no potential conflicts of interest, financial or otherwise.

JAAPA : Official Journal of the American Academy of Physician Assistants
|June 10, 2024
PubMed
Summary
This summary is machine-generated.

Irritable bowel syndrome (IBS) is a complex condition causing abdominal pain and altered bowel habits. A positive diagnostic approach and multimodal treatment can improve symptom relief and reduce healthcare costs.

More Related Videos

Author Spotlight: Developing a Rat Model for Pouchitis Research and Treatment
04:05

Author Spotlight: Developing a Rat Model for Pouchitis Research and Treatment

Published on: May 31, 2024

353
Investigating Intestinal Inflammation in DSS-induced Model of IBD
08:43

Investigating Intestinal Inflammation in DSS-induced Model of IBD

Published on: February 1, 2012

67.2K

Related Experiment Videos

Last Updated: Jun 24, 2025

Perturbations of Circulating miRNAs in Irritable Bowel Syndrome Detected Using a Multiplexed High-throughput Gene Expression Platform
10:37

Perturbations of Circulating miRNAs in Irritable Bowel Syndrome Detected Using a Multiplexed High-throughput Gene Expression Platform

Published on: November 30, 2016

8.3K
Author Spotlight: Developing a Rat Model for Pouchitis Research and Treatment
04:05

Author Spotlight: Developing a Rat Model for Pouchitis Research and Treatment

Published on: May 31, 2024

353
Investigating Intestinal Inflammation in DSS-induced Model of IBD
08:43

Investigating Intestinal Inflammation in DSS-induced Model of IBD

Published on: February 1, 2012

67.2K

Area of Science:

  • Gastroenterology
  • Internal Medicine
  • Clinical Practice

Background:

  • Irritable bowel syndrome (IBS) is a prevalent gastrointestinal disorder.
  • It is characterized by chronic abdominal pain and altered bowel habits.
  • Misunderstanding IBS leads to delayed diagnosis, reduced quality of life, and high healthcare costs.

Purpose of the Study:

  • To advance clinicians' understanding of IBS as a complex biopsychosocial process.
  • To promote a positive diagnostic strategy over a diagnosis of exclusion.
  • To highlight the benefits of a multimodal treatment approach.

Main Methods:

  • Review of current understanding and diagnostic approaches for IBS.
  • Emphasis on a positive diagnostic strategy.
  • Integration of multimodal treatment modalities.

Main Results:

  • A positive diagnostic strategy expedites time to diagnosis.
  • Multimodal treatment facilitates symptom relief.
  • Improved understanding and management reduce financial expenditure.

Conclusions:

  • Advancing clinical understanding of IBS is crucial.
  • Adopting a positive diagnostic strategy and multimodal treatment is effective.
  • This approach improves patient outcomes and reduces healthcare burden.